GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mark Marcellus who wrote (4035)	12/5/2001 9:19:21 PM
From: Mad2	Read Replies (1) of 5582

Interesting. the answer that best applies is "E" of course. BTW using the figures you posted, GUMM has 25-16.5 mil or 8.5 mil to spend/burn or use as current capital. Thus using the 65 mil market cap the enterprise value attributed by the market is 65-8.5 or 56.5 mil. Assuming GUMM can predictably generate roughly 5-6 mil in aftertax income assuming no growth (or other capital demands) then they are fairly valued. Is Zicam worth 56.5 mil. Davidson apparently doesn't think so as the enterprise value paid values Zicam business at 16.5/.4 or $41.25 mil Sorry folks GUMM price has a lot of optimism built in. I do suspect that Zicam might be leveraged by a larger consumer products company (distribution, name recognition etc). Alternatly one can hope the greater fool theory comes back into vogue. BR, mad2

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next